ZPHC Retatrutide 60 mg (Retatrutide ZPHC) 5 vials of 12 mg

Product Discontinued

ZPHC Retatrutide 60 mg (Retatrutide ZPHC) 5 vials of 12 mg

MOQ : 5 Boxes

ZPHC Retatrutide 60 mg (Retatrutide ZPHC) 5 vials of 12 mg Specification

Products Category
Pharmaceuticals / Peptides

Product Type
Retatrutide (Polypeptide hormone analogue)

Ingredients
Retatrutide 60 mg (5 vials of 12 mg each)

Material
Sterile lyophilized powder

Physical Form
Powder for injection

Age Group
Adults

Dosage Guidelines
Reconstitute with provided solvent, administer as directed by physician

Dosage
12 mg per vial, as prescribed by a healthcare professional

Weight
60 mg (Total pack content)

Volume
5 vials x 12 mg (total 60 mg)

Color
White (powder)

Intended Use
Research chemical / clinical investigational use only

Route of Administration
Subcutaneous injection

Application
Research, clinical use for metabolic disorders or weight management

Shelf Life
Typically 24-36 months from manufacture date

Packaging Type
Box with 5 glass vials in blister tray

Storage Instructions
Store in a cool, dry place, ideally between 2C and 8C, protect from light

ZPHC Retatrutide 60 mg (Retatrutide ZPHC) 5 vials of 12 mg Trade Information

Minimum Order Quantity
5 Boxes

Payment Terms
Telegraphic Transfer (T/T)

Supply Ability
10000 Boxes Per Week

Delivery Time
5 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

ZPHC Retatrutide 60 mg (Retatrutide ZPHC) 5 vials of 12 mg About

Retatrutide is a "triple agonist" that targets GLP-1, GIP, and glucagon receptors. This means it works on multiple pathways to help with appetite suppression, insulin sensitivity, and fat loss

Advanced Research Formulation

ZPHC Retatrutide 60 mg features a pure, lyophilized peptide intended for investigational research and clinical studies. Each vial is precisely dosed and packaged in a glass container to maintain product integrity during storage and transport. The box includes a blister tray for secure handling and easy access.

Secure and Convenient Packaging

Supplied in a box containing five glass vials, the packaging is designed to ensure product sterility and ease of use. The blister tray provides protection against contamination and simplifies organization for research teams or clinical staff, making dosing and administration more straightforward.

Strict Storage Recommendations

For optimal stability and effectiveness, store ZPHC Retatrutide in a cool, dry place at temperatures between 2C and 8C, and keep it protected from light. Adhering to these instructions ensures the compound maintains its intended potency throughout its 24-36 month shelf life.

FAQ's of ZPHC Retatrutide 60 mg (Retatrutide ZPHC) 5 vials of 12 mg:

Q: How is ZPHC Retatrutide 60 mg prepared and administered?

A: ZPHC Retatrutide 60 mg should be reconstituted with the provided solvent before use. After reconstitution, the solution is administered via subcutaneous injection as prescribed by a qualified healthcare professional.

Q: What are the recommended storage conditions for this product?

A: Retatrutide vials should be kept in a cool, dry environment, ideally between 2C and 8C, and shielded from direct light. This ensures the stability and shelf life of the product are maintained.

Q: When should ZPHC Retatrutide be used?

A: This peptide is intended for research or clinical use investigating metabolic disorders and weight management. It should be utilized only under the guidance of a healthcare professional within approved research or investigational protocols.

Q: Where does the Retatrutide come from and who can distribute it?

A: Retatrutide ZPHC is available through distributors, suppliers, and traders in India who are authorized to provide research chemicals and investigational products to qualified professionals.

Q: What is the application and benefit of Retatrutide ZPHC?

A: The main application is in the research of therapies for metabolic disorders and weight management. Benefits include its precise dosage form and suitability for controlled clinical investigations, contributing valuable data for potential therapeutic use.

Q: Is this product intended for all age groups?

A: No, ZPHC Retatrutide 60 mg is intended for adult use only, as specified by the manufacturer and as is common in research and investigational settings.